Antiviral Activity of Approved Antibacterial, Antifungal, Antiprotozoal and Anthelmintic Drugs: Chances for Drug Repurposing for Antiviral Drug Discovery

Leena Abdulaziz1 Department of Pharmacology, Faculty of Pharmacy, Omdurman Islamic University, Khartoum, 14415, SudanView further author information

Esraa Elhadi1 Department of Pharmacology, Faculty of Pharmacy, Omdurman Islamic University, Khartoum, 14415, Sudan;2 Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing, 210009, People’s Republic of ChinaView further author information

Ejlal A Abdallah3 Department of Pharmacology and Pharmacy Practice, Faculty of Pharmacy, Sudan University of Science and Technology, Khartoum, 11111, SudanView further author information

Fadlalbaseer A Alnoor4 Department of Pharmacology, Faculty of Pharmacy, National University, Khartoum, 11111, SudanView further author information

Bashir A Yousef5 Department of Pharmacology, Faculty of Pharmacy, University of Khartoum, Khartoum, 11111, SudanCorrespondence[email protected]

https://orcid.org/0000-0001-7832-4556 View further author information

Antiviral Activity of Approved Antibacterial, Antifungal, Antiprotozoal and Anthelmintic Drugs: Chances for Drug Repurposing for Antiviral Drug Discovery

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Antiviral Activity of Approved Antibacterial, Antifungal, Antiprotozoal and Anthelmintic Drugs: Chances for Drug Repurposing for Antiviral Drug Discovery

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date